However, a statistical difference in OS, PFS, disease‐free survival (DFS) and DSS in HCC patients with or without RHBDF2 alterations was not observed with the Kaplan–Meier plotter (Fig. 5D). This evidence concerns the gene RHBDF2 and hepatocellular carcinoma.